Terence Novak serves as Executive at CURAXIS PHARMACEUTICAL Corp, where they oversee executive responsibilities. Since joining the company, Terence Novak has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 9, 2014 involved receiving (via award) 500,000 shares valued at $0.
Terence Novak currently holds 500,000 shares of CURAXIS PHARMACEUTICAL Corp (CURX.PK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Terence Novak has been a net neutral trader of CURX.PK stock. They have purchased $0 and sold $0 worth of shares.
Terence Novak's most recent insider trade was on Mar 9, 2014, when they sold 500,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.04 |
| Discretionary |
| Nov 17, 2011 | CURX.PK | $5.7K | Award | 70,671 | $0.08 | Discretionary |